HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Montserrat Pinent Selected Research

proanthocyanidin

6/2021Grape-Seed Proanthocyanidin Extract Reverts Obesity-Related Metabolic Derangements in Aged Female Rats.
1/2020Health-Promoting Properties of Proanthocyanidins for Intestinal Dysfunction.
12/2019Long-Lasting Effects of GSPE on Ileal GLP-1R Gene Expression Are Associated with a Hypomethylation of the GLP-1R Promoter in Female Wistar Rats.
4/2019Grape-Seed Proanthocyanidins are Able to Reverse Intestinal Dysfunction and Metabolic Endotoxemia Induced by a Cafeteria Diet in Wistar Rats.
12/2018The co-administration of proanthocyanidins and an obesogenic diet prevents the increase in intestinal permeability and metabolic endotoxemia derived to the diet.
3/2018Grape seed proanthocyanidins influence gut microbiota and enteroendocrine secretions in female rats.
6/2017A specific dose of grape seed-derived proanthocyanidins to inhibit body weight gain limits food intake and increases energy expenditure in rats.
1/2017Chronic supplementation with dietary proanthocyanidins protects from diet-induced intestinal alterations in obese rats.
1/2016Acutely administered grape-seed proanthocyanidin extract acts as a satiating agent.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Montserrat Pinent Research Topics

Disease

12Inflammation (Inflammations)
12/2022 - 07/2011
12Body Weight (Weight, Body)
06/2022 - 10/2010
9Obesity
06/2021 - 12/2012
6Insulin Resistance
12/2022 - 10/2010
3Type 2 Diabetes Mellitus (MODY)
07/2019 - 09/2012
3Endotoxemia
04/2019 - 12/2018
2Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2018 - 10/2010
1Allergic Rhinitis
01/2022
1Ketosis
11/2020
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2020
1Diabetes Mellitus
01/2020
1Glucose Intolerance
07/2019
1Hypertrophy
01/2019
1Weight Gain
01/2018
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2014
1Adenocarcinoma
01/2014
1Septic Shock (Toxic Shock Syndrome)
07/2013
1Sepsis (Septicemia)
07/2013
1Prediabetic State (Prediabetes)
01/2013
1B-Cell Lymphoma (Lymphoma, B Cell)
10/2012
1Hyperglycemia
01/2012
1Coronary Disease (Coronary Heart Disease)
10/2008

Drug/Important Bio-Agent (IBA)

11Proanthocyanidins (Procyanidins)IBA
01/2019 - 01/2012
9proanthocyanidinIBA
06/2021 - 01/2016
9procyanidinIBA
01/2015 - 10/2010
6Glucose (Dextrose)FDA LinkGeneric
07/2019 - 10/2010
4Insulin (Novolin)FDA Link
12/2022 - 01/2013
4FlavonoidsIBA
12/2019 - 10/2010
3CytokinesIBA
01/2022 - 11/2012
3Glucagon-Like Peptide 1 (GLP 1)IBA
12/2019 - 02/2014
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 11/2012
3PolyphenolsIBA
10/2014 - 11/2012
3LipopolysaccharidesIBA
07/2013 - 04/2012
2EndotoxinsIBA
01/2019 - 07/2013
2Peroxidase (Myeloperoxidase)IBA
01/2019 - 01/2017
2CarbohydratesIBA
12/2018 - 01/2017
2LipidsIBA
01/2018 - 12/2012
2Fatty Acids (Saturated Fatty Acids)IBA
10/2016 - 10/2014
2FructoseIBA
01/2015 - 01/2012
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
10/2014 - 04/2012
2AntioxidantsIBA
07/2013 - 10/2008
2PhosphoproteinsIBA
11/2012 - 04/2012
2Proteins (Proteins, Gene)FDA Link
10/2012 - 07/2011
1dimemorfan (AT 17)IBA
06/2022
1Glucagon (Glukagon)FDA Link
11/2020
1Hormones (Hormone)IBA
01/2020
1Peptides (Polypeptides)IBA
07/2019
1Grape Seed ProanthocyanidinsIBA
04/2019
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2019
1Butyrates (Butyrate)IBA
01/2019
1Phenobarbital (Luminal)FDA Link
01/2019
1OvalbuminIBA
01/2019
1Messenger RNA (mRNA)IBA
06/2017
1Nonesterified Fatty Acids (NEFA)IBA
10/2016
1LeptinIBA
10/2016
1Triglycerides (Triacylglycerol)IBA
10/2016
1procyanidin B2IBA
02/2015
1InflammasomesIBA
02/2015
1Gallic AcidIBA
01/2014
1InterleukinsIBA
07/2013
1Pharmaceutical PreparationsIBA
07/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2013
1MicroRNAs (MicroRNA)IBA
01/2013
1Biomarkers (Surrogate Marker)IBA
01/2013
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
11/2012
1ResveratrolIBA
11/2012
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
10/2012
1Dipeptidyl-Peptidase IV InhibitorsIBA
09/2012
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
09/2012
1Eicosapentaenoic AcidIBA
04/2012
1Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2012
1Docosahexaenoic AcidsIBA
04/2012
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
07/2011

Therapy/Procedure

1Therapeutics
12/2016
1Intraperitoneal Injections
07/2013